These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9271006)

  • 1. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression.
    Li R; el-Mallakh RS; Harrison L; Changaris DG; Levy RS
    Mol Chem Neuropathol; 1997 May; 31(1):65-72. PubMed ID: 9271006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabain induction of cycling of multiple spike responses in hippocampal slices is delayed by lithium.
    El-Mallakh RS; Schurr A; Payne RS; Li R
    J Psychiatr Res; 2000; 34(2):115-20. PubMed ID: 10758252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine reduces mania-like symptoms in animal models.
    Gao Y; Payne RS; Schurr A; Hougland T; Lord J; Herman L; Lei Z; Banerjee P; El-Mallakh RS
    Psychiatry Res; 2011 Aug; 188(3):366-71. PubMed ID: 21269711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
    Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent hyperactivity following a single intracerebroventricular dose of ouabain.
    Ruktanonchai DJ; El-Mallakh RS; Li R; Levy RS
    Physiol Behav; 1998 Feb; 63(3):403-6. PubMed ID: 9469734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives.
    Valvassori SS; Dal-Pont GC; Resende WR; Varela RB; Lopes-Borges J; Cararo JH; Quevedo J
    Transl Psychiatry; 2019 Jun; 9(1):158. PubMed ID: 31164628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness.
    Decker S; Grider G; Cobb M; Li XP; Huff MO; El-Mallakh RS; Levy RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):455-62. PubMed ID: 10836492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
    Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
    J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain.
    Brocardo PS; Budni J; Pavesi E; Franco JL; Uliano-Silva M; Trevisan R; Terenzi MG; Dafre AL; Rodrigues AL
    Bipolar Disord; 2010 Jun; 12(4):414-24. PubMed ID: 20636639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Varela RB; Peterle BR; Gava FF; Mina FG; Cararo JH; Carvalho AF; Quevedo J
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):877-885. PubMed ID: 29020306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain.
    Lopes-Borges J; Valvassori SS; Varela RB; Tonin PT; Vieira JS; Gonçalves CL; Streck EL; Quevedo J
    Pharmacol Biochem Behav; 2015 Jan; 128():89-95. PubMed ID: 25433326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ouabain on sodium pump alpha-isoform expression in an animal model of mania.
    Hamid H; Gao Y; Lei Z; Hougland MT; El-Mallakh RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1103-6. PubMed ID: 19524007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular administration of ouabain as a model of mania in rats.
    El-Mallakh RS; El-Masri MA; Huff MO; Li XP; Decker S; Levy RS
    Bipolar Disord; 2003 Oct; 5(5):362-5. PubMed ID: 14525557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates tyrosine hydroxylase through extracellular signal-regulated kinase in rat striatum.
    Yu HS; Kim SH; Park HG; Kim YS; Ahn YM
    Neurochem Int; 2011 Nov; 59(6):779-86. PubMed ID: 21871514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An animal model for mania: preliminary results.
    el-Mallakh RS; Harrison LT; Li R; Changaris DG; Levy RS
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Sep; 19(5):955-62. PubMed ID: 8539431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking human bipolar ion dysregulation models mania in rats.
    Herman L; Hougland T; El-Mallakh RS
    Neurosci Biobehav Rev; 2007; 31(6):874-81. PubMed ID: 17720496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ouabain on cytokine/chemokine levels in an animal model of mania.
    Tonin PT; Valvassori SS; Lopes-Borges J; Mariot E; Varela RB; Teixeira AL; Quevedo J
    J Neuroimmunol; 2014 Nov; 276(1-2):236-9. PubMed ID: 25288301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actions of ouabain and lithium chloride on cytosolic Ca2+ in single chromaffin cells.
    De la Fuente MT; Maroto R; Esquerro E; Sánchez-García P; García AG
    Eur J Pharmacol; 1996 Jun; 306(1-3):219-26. PubMed ID: 8813635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.
    Jornada LK; Valvassori SS; Steckert AV; Moretti M; Mina F; Ferreira CL; Arent CO; Dal-Pizzol F; Quevedo J
    J Psychiatr Res; 2011 Feb; 45(2):162-8. PubMed ID: 20627318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.